Novartis Vaccines

Quick facts

Marketed products

• Cell-derived influenza vaccine
• Fluad_MF59-adjuvanted trivalent influenza subunit vaccine
• Haemophilus influenza type b conjugate vaccine
• MenC · Immunology
  MenC stimulates the immune system to produce antibodies against the capsular polysaccharide of Neisseria meningitidis serogroup C.
• Meningococcal B vaccine
• Rabies · Other
• TBE vaccine for adults
• Varicella · Other

Phase 3 pipeline

• Adjuvanted seasonal influenza vaccine
• MMR-V
• Zagreb · Other

Phase 1 pipeline

• GBS glycoconjugate vaccine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Novartis Vaccines portfolio CI brief
• Novartis Vaccines pipeline updates RSS